IFN-γ Affects Homing of Diabetogenic T Cells1

IFN-γ is a cytokine with pleiotropic functions that participates in immune and autoimmune responses. The lack of IFN-γ is known to delay the development of autoimmune diabetes in nonobese diabetic (NOD) mice. Splenocytes from diabetic NOD and IFN-γ knockout (KO) NOD mice transfer diabetes into NOD recipients equally well. However, adoptive transfer of diabetogenic T cells from NOD mice into NOD.IFN-γ-KO or NOD mice lacking β-chain of IFN-γ receptor (NOD.IFN-γRβ-KO) appeared to be much less efficient. We found that IFN-γ influences the ability of diabetogenic cells to penetrate pancreatic islets. Tracing in vivo of insulin-specific CD8+ T cells has shown that homing of these cells to the islets of Langerhans was affected by the lack of IFN-γ. While adhesion of insulin-specific CD8+ cells to microvasculature was normal, the diapedesis was significantly impaired. This effect was reversible by treatment of the animals with rIFN-γ. Thus, IFN-γ may, among other effects, influence immune and autoimmune responses by supporting the homing of activated T cells.

[1]  Bernhard Moser,et al.  Lymphocyte traffic control by chemokines , 2001, Nature Immunology.

[2]  P. Rothman,et al.  Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. , 2000, Diabetes.

[3]  C. Mackay,et al.  T-cell function and migration. Two sides of the same coin. , 2000, The New England journal of medicine.

[4]  J. Todd,et al.  NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. , 2000, Diabetes.

[5]  J. Todd,et al.  The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. , 2000, Immunity.

[6]  C. Caux,et al.  Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis1 , 2000, The Journal of Immunology.

[7]  A. Tevaarwerk,et al.  Protection of Nonobese Diabetic Mice from Diabetes by Gene(s) Closely Linked to IFN-γ Receptor Loci1 , 2000, The Journal of Immunology.

[8]  P. Santamaria,et al.  IL-1α, IL-1β, and IFN-γ mark β cells for Fas-dependent destruction by diabetogenic CD4+ T lymphocytes , 2000 .

[9]  D. Willenborg,et al.  Kinetics and Polarization of the Membrane Expression of Cytokine‐induced ICAM‐1 on Rat Brain Endothelial Cells , 2000, Journal of neuropathology and experimental neurology.

[10]  F. Wong,et al.  Neonatal Tumor Necrosis Factor α Promotes Diabetes in Nonobese Diabetic Mice by Cd154-Independent Antigen Presentation to Cd8+ T Cells , 2000, The Journal of experimental medicine.

[11]  A. Chervonsky Apoptotic and effector pathways in autoimmunity. , 1999, Current opinion in immunology.

[12]  G. Randolph,et al.  Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes , 1999, Journal of leukocyte biology.

[13]  T. Kawai,et al.  Selective diapedesis of Th1 cells induced by endothelial cell RANTES. , 1999, Journal of immunology.

[14]  A. Yoshimura,et al.  SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality , 1999, Cell.

[15]  C. Janeway,et al.  Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library , 1999, Nature Medicine.

[16]  G. Prud’homme,et al.  Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein , 1999, Gene Therapy.

[17]  J. Katz,et al.  In Autoimmune Diabetes the Transition from Benign to Pernicious Insulitis Requires an Islet Cell Response to Tumor Necrosis Factor α , 1999, The Journal of experimental medicine.

[18]  G. Pascual,et al.  Modulation of PECAM-1 (CD31) Expression in Human Endothelial Cells: Effect of IFNγ and IL-10 , 1999, Journal of Vascular Research.

[19]  I. Cohen,et al.  The pathogenicity of islet‐infiltrating lymphocytes in the non‐obese diabetic (NOD) mouse , 1999, Clinical and experimental immunology.

[20]  R. Schreiber,et al.  IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. , 1998, The Journal of clinical investigation.

[21]  D. Sampath,et al.  Patterns for RANTES Secretion and Intercellular Adhesion Molecule 1 Expression Mediate Transepithelial T Cell Traffic Based on Analyses In Vitro and In Vivo , 1998, The Journal of experimental medicine.

[22]  C. Mackay,et al.  The chemokine receptor CXCR3 mediates rapid and shear‐resistant adhesion‐induction of effector T lymphocytes by the chemokines IP10 and Mig , 1998, European journal of immunology.

[23]  D. Hafler,et al.  Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes , 1998, Nature.

[24]  C. Benoist,et al.  Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Bouwens,et al.  Effect of Interferon-γ and Glucose on Major Histocompatibility Complex Class I and Class II Expression by Pancreatic β- and Non-β-Cells1 , 1997 .

[26]  C. Janeway,et al.  The Role of Fas in Autoimmune Diabetes , 1997, Cell.

[27]  M. V. von Herrath,et al.  Interferon-γ Is Essential for Destruction of β Cells and Development of Insulin-dependent Diabetes Mellitus , 1997, The Journal of experimental medicine.

[28]  F. Nicoletti,et al.  The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse. , 1996, Endocrinology.

[29]  B. Ripley,et al.  Modern Applied Statistics with S-Plus. , 1996 .

[30]  H. Ruffner,et al.  Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice. , 1996, Immunity.

[31]  Xiaojian Huang,et al.  Genetic Absence of γ-Interferon Delays but Does Not Prevent Diabetes in NOD Mice , 1996, Diabetes.

[32]  R. Pujol-Borrell,et al.  Expression of Transporter Associated With Antigen Processing–1 in the Endocrine Cells of Human Pancreatic Islets: Effect of Cytokines and Evidence of Hyperexpression in IDDM , 1996, Diabetes.

[33]  J. Monaco,et al.  Identification of MECL-1 (LMP-10) as the third IFN-gamma-inducible proteasome subunit. , 1996, Journal of immunology.

[34]  D. Lauffenburger,et al.  Cell Migration: A Physically Integrated Molecular Process , 1996, Cell.

[35]  B. Gumbiner,et al.  Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis , 1996, Cell.

[36]  C. Janeway,et al.  CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells , 1996, The Journal of experimental medicine.

[37]  R. Coffman,et al.  Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. , 1995, Science.

[38]  W. Suarez-Pinzon,et al.  IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. , 1995, Journal of immunology.

[39]  R. Flavell,et al.  Class II transactivator regulates the expression of multiple genes involved in antigen presentation , 1995, The Journal of experimental medicine.

[40]  D. Greiner,et al.  Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. , 1995, Journal of immunology.

[41]  A. B. Lyons,et al.  Determination of lymphocyte division by flow cytometry. , 1994, Journal of immunological methods.

[42]  N. Sarvetnick,et al.  Induction of vascular addressins and adhesion molecules in the pancreas of IFN-gamma transgenic mice. , 1994, Journal of immunology.

[43]  F. Ho,et al.  Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation. , 1994, Journal of clinical pathology.

[44]  A. Bradley,et al.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.

[45]  R. Zinkernagel,et al.  Immune response in mice that lack the interferon-gamma receptor. , 1993, Science.

[46]  P. Bedossa,et al.  Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice , 1991, Nature.

[47]  P. Bedossa,et al.  Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. , 1991, Journal of autoimmunity.

[48]  L. Harrison,et al.  Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. , 1991, The Journal of clinical investigation.

[49]  N. Sarvetnick,et al.  Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ , 1990, Nature.

[50]  C. Janeway,et al.  Prevention of Diabetes in NOD Mice by Injection of Autoreactive T-Lymphocytes , 1989, Diabetes.

[51]  E. Leiter,et al.  MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice , 1989, The Journal of experimental medicine.

[52]  N. Sarvetnick,et al.  Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma , 1988, Cell.

[53]  Linda S. Wicker,et al.  NOD Idd 5 Locus Controls Insulitis and Diabetes and Overlaps the Orthologous CTLA 4 / IDDM 12 and NRAMP 1 Loci in Humans , 2000 .

[54]  P. Rothman,et al.  Interferon-Receptor Signaling Is Dispensable in the Development of Autoimmune Type 1 Diabetes in NOD Mice , 2000 .

[55]  L. Bradley,et al.  Regulation of development and function of memory CD4 subsets. , 2000 .

[56]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.